e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Management of airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy
R. Buhl, J. Haughney, O. C. P. van Schayck, J. Ostinelli, T. Ekström, L. Jörgensen, M. Aubier (Germany; Aberdeen, United Kingdom; , Netherlands; Rueil-Malmaison, Paris, France; Södertälje, Sweden)
Source:
Annual Congress 2010 - Management of airway disease
Session:
Management of airway disease
Session type:
Thematic Poster Session
Number:
4565
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Buhl, J. Haughney, O. C. P. van Schayck, J. Ostinelli, T. Ekström, L. Jörgensen, M. Aubier (Germany; Aberdeen, United Kingdom; , Netherlands; Rueil-Malmaison, Paris, France; Södertälje, Sweden). Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy. Eur Respir J 2010; 36: Suppl. 54, 4565
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Budesonide/formoterol as maintenance and reliever therapy reduces asthma exacerbations
versus
a higher maintenance dose of budesonide/formoterol or salmeterol/fluticasone
Source: Eur Respir J 2006; 28: Suppl. 50, 205s
Year: 2006
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy
Source: Eur Respir J 2010; 36: 524-530
Year: 2010
Short-acting bronchodilator and oral steroid use in asthma patients prescribed either concurrent beclometasone and salmeterol or combined salmeterol/fluticasone
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004
Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Budesonide/formoterol maintenance and reliever therapy use in elderly asthma patients
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010
Budesonide/formoterol for maintenance and relief
vs.
higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS)
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007
The inhaled corticosteroid/long-acting ß-agonist maintenance and reliever therapy regimen: where to from here?
Source: Eur Respir J, 51 (1) 1702338; 10.1183/13993003.02338-2017
Year: 2018
Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
Source: Eur Respir J, 51 (1) 1701688; 10.1183/13993003.01688-2017
Year: 2018
Episodic high reliever use with budesonide/formoterol maintenance and reliever therapy confers added protection against asthma exacerbations
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007
Combination therapy with maintenance budesonide and formoterol in COPD
Source: Eur Respir J 2004; 24: 1070
Year: 2004
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Safety of formoterol reliever therapy compared with terbutaline in asthmatic children taking anti-inflammatory therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 431s
Year: 2002
Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
Source: ERJ Open Res 2016: 00106-2015
Year: 2016
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting ß2-agonist in persistent asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010
Budesonide–formoterol reliever therapy in intermittent
versus
mild persistent asthma
Source: Eur Respir J, 57 (2) 2003064; 10.1183/13993003.03064-2020
Year: 2021
Stability of overall asthma control achieved with budesonide/formoterol maintenance + reliever therapy
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept